NCT01390844
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Hepatitis C, Chronic
Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.
699 public trials
3 recruiting studies
Hepatitis C, Chronic trial results
NCT01544920
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT00793793
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1220.2.10 Boehringer Ingelheim Investigational Site San Francisco, California, United States
- 1220.2.15 Boehringer Ingelheim Investigational Site San Francisco, California, United States
- 1220.2.17 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States
- 1220.2.11 Boehringer Ingelheim Investigational Site New York, United States
NCT01457755
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Birmingham Gastroenterology Associates Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Digestive Health Specialists of the Southeast, PA Dothan, Alabama, United States
- Mayo Clinic Phoenix, Arizona, United States
NCT03020004
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
Not specified
NCT01879462
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
NCT02014571
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Juan, Puerto Rico
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT01314261
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
- Locations
-
- Site Reference ID/Investigator# 56623 Birmingham, Alabama, United States
- Site Reference ID/Investigator# 48476 Los Angeles, California, United States
- Site Reference ID/Investigator# 51345 Orlando, Florida, United States
- Site Reference ID/Investigator# 51498 Honolulu, Hawaii, United States
Completed
A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China
NCT03430830
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- First Hospital of Zhejiang Province Hangzhou, Zhejiang, China